The recent trend of transdermal drug delivery system development

Yakugaku Zasshi

Volumn 127, Issue 4, 2007, Pages 655-662

  Higo, Naruhito ^a  

^a HISAMITSU PHARMACEUTICAL CO INC   (Japan)

Author keywords

Iontophoresis; Physical transdermal enhancement; Sonophoresis; Transdermal Drug Delivery System

Indexed keywords

CLONIDINE; ESTRADIOL; FENTANYL; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; LIDOCAINE; NICOTINE; OXYBUTYNIN; PEPTIDE; SCOPOLAMINE; SELEGILINE; TULOBUTEROL;

DRUG DELIVERY SYSTEM; DRUG PENETRATION; ELECTRIC FIELD; IONTOPHORESIS; REVIEW; SKIN; TRANSDERMAL DRUG ADMINISTRATION; ULTRASOUND;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; ELECTROPORATION; HUMANS; IONTOPHORESIS; MACROMOLECULAR SUBSTANCES; MOLECULAR WEIGHT; PERMEABILITY; PHARMACOKINETICS; SKIN; ULTRASONICS; VACCINES;

EID: 34047232233     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.655     Document Type: Review

References (33)

1. Uematsu T., Nakano M., Kosuge K., Kanamaru M., Nakashima M., Eur. J. Pharmacol., 44, 361-364 (1993).
2. Fujiwara T., J. New Remedies Clin., 48, 1015-1024 (1999).
3. Stoughton R. B., McCure W. O., Drug Develop. Ind. Pharm., 9, 725-744 (1983).
4. Yano T., Higo N., Furukawa K., Fukuda K., Tsuji M., Noda K., J. Pharm. Pharmacol., 45, 775-778 (1993).
5. Kim A., Green P. G., Rao G., Guy R. H., Pharm. Res., 10, 1315-1320 (1993).
6. Marro D., Kalia Y. N., Delgado-Charro M. B., Guy R. H., Pharm. Res., 18, 1701-1708 (2001).
7. Chen T., Langer R., Weaver J. C., J. Derm. Invest., 3, 159-165 (1998).
8. Gupta S. K., Southam M., Sathyam G., Klausner M., J. Pharm. Sci., 87, 976-981 (1998).
9. Viscusi E. R., Reynolds L., Chung F., Atkinson L. E., Khanna S., JAMA, 291, 1333-1341 (2004).
10. Tierney M. J., Garg S., Ackerman N. R., Fermi S. J., Kennedy J., Lopatin M., Potts R. O., Tamada J. A., Diabetes Technol. Ther., 2, 199-207 (2000).
11. Terahara T., Mitragotri S., Kost J., Langer R., Int. J. Pharm., 235, 35-42 (2002).
12. Frederick J. R., "Ultrasound Engineering," John Wiley, New York, 1980.
13. Gaetner W., J. Acoust. Soc. Am., 26, 977-980 (1954).
14. Mitragotri S., Blankschtein D., Langer R., Pharm. Res., 13, 411-420 (1996).
15. Mitragotri S., Edwards D., Blankschtein D., Langer R., J. Pharm. Sci., 84, 697-706 (1995).
16. Mitragotri S., Farrel J., Tang H., Terahara T., Kost J., Langer R., J. Control. Release, 63, 41-52 (2000).
17. Mitragotri S., Debanjan R., Farrel J., Tang H., Yu B., Kost J., Langer R., J. Pharm. Sci., 89, 892-900 (2000).
18. Suslick K. S., "Ultrasound: it's chemical, physical and biological effects," ed. by Suslick K. S., VCX, New York, 1988.
19. Liu J., Lewis T., Prausnitz M., Pharm. Res., 15, 918-923 (1998).
20. Tang H., Mitragotri S., Blankschtein D., Langer R., J. Pharm. Sci., 90, 545-568 (2001).
21. Bommannan D. B., Tamada J., Leung L., Potts R., Pharm. Res., 11, 1809-1814 (1994).
22. Prausnitz M. R., Pliquett U., Langer R., Weaver J. C., Pharm. Res., 11, 1834-1837 (1994).
23. Prausnitz M. R., Adv. Drug Deliv. Rev., 56, 581-587 (2004).
24. Bommannan D. B., Tamada J., Leung L., Potts R. O., Pharm. Res., 11, 1809-1814 (1994).
25. Chang S. L., Hofmann G. A., Zhang L., Deftos L. J., Banga A. K., J. Control. Release, 66, 127-133 (2000).
26. Pliquett U. F., Gusbeth C. A., Weaver J. C., J. Control. Release, 68, 373-386 (2000).
27. Le L., Kost J., Mitragotri S., Pharm. Res., 17, 1151-1154 (2000).
28. Tokumoto S., Higo N., Sugibayashi K., Int. J. Pharm., 326, 13-19 (2006).
29. Tokumoto S., Mori K., Higo N., Sugibayashi K., J. Control. Release, 105, 296-304 (2005).
30. Tezel A., Paliwal S., Shen Z., Mitragotri S., Vaccine, 23, 3800-3807 (2005).
31. Frech S. A., Kenney R. T., Spyr C. A., Lazar H., Viret J.-F., Herzog C., Gluck R., Glenn G. M., Vaccine, 23, 946-950 (2005).
32. Zhang L., Nolan E., Kreitschitz S., Rabussay D. P., Biochim. Biophys. Acta, 1572, 1-9 (2002).
33. Seo N., Tokura Y., Nishijima T., Hashizume H., Furukawa F., Takigawa M., Proc. Natl. Acad. Sci. U. S. A., 97, 371-376 (2000).